Table I. Description of the sample cohort.
Stagea | TNMb | Agec | Sex | Tumor size(cm) | Tumor histologyd |
---|---|---|---|---|---|
Adenoma | 84 | F | Large | Severe dysplasia | |
Adenoma | 79 | F | Large | Severe dysplasia | |
Adenoma | 72 | F | 2 | Severe dysplasia | |
Adenoma | 64 | M | 10 | Severe dysplasia | |
Adenoma | 52 | M | 2 | Severe dysplasia | |
A | T2N0M0 | 49 | F | 4 | Adeno, G1 |
A | T2N0M0 | 59 | M | 3 | Adeno, G2 |
A | T2N0M0 | 59 | M | 14 | Adeno, G2 |
A | T2N0M0 | 53 | M | 2 | Adeno, G2 |
B | T3N0M0 | 87 | M | 5 | Adeno, G2 |
B | T3N0M0 | 71 | M | 7 | Adeno, G2 |
B | T3N0M0 | 76 | F | 7 | Adeno, G2 |
B | T3N0M0 | 56 | M | 5 | Adeno, G2 |
C | T3N1M0 | 74 | M | 3 | Adeno, G2 |
C | T3N1M0 | 61 | M | 4 | Adeno, G2 |
C | T3N1M0 | 55 | F | 5 | Adeno, G2 |
C | T3N2M0 | 84 | M | 4 | Adeno, G2 |
D | T3N1M1 | 56 | F | 7 | Adeno, G2 |
D | T3N2M1 | 82 | M | 5 | Adeno, G2 |
D | T3N2M1 | 66 | M | 5 | Adeno, G3 |
D | T4N2M1 | 28 | M | 6 | Adeno, G3 |
D | T3N1M1 | 50 | M | 5 | Adeno, G3 |
D | T3N2M1 | 64 | F | 3 | Adeno, G3 |
a Dukes A-D,
b TNM, tumor node metastasis,
c Age at diagnosis,
d Dysp.gravis = Dysplasia gravis, Adeno = Adenocarcinoma, G = Grade(1–4, WHO).